Back to Results
First PageMeta Content
Novartis / Regulatory compliance / Vaccine / Biology / Pharmaceutical industry / Medicine / Frank E. Sheeder III / Office of Inspector General /  U.S. Department of Health and Human Services / United States Department of Health and Human Services / Inspector General


Compliance Declaration California Pharmaceutical Compliance Law, SB 1765 Novartis Vaccines and Diagnostics, Inc. has developed an Integrity and Compliance Program in accordance with the “Compliance Program Guidance for
Add to Reading List

Document Date: 2014-06-23 10:25:29


Open Document

File Size: 159,35 KB

Share Result on Facebook

Company

SB 1765 Novartis Vaccines and Diagnostics Inc. / /

Organization

U.S. Department of Health and Human Services / office of Inspector General / /

URL

http /

SocialTag